Announcements Trials
Browse Landscape

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 2Breast Neoplasms 2Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 33Pemetrexed 25Cisplatin 23Paclitaxel 20Radiotherapy 16Docetaxel 16Gemcitabine 15durvalumab 14Radiosurgery 14pembrolizumab 13Nivolumab 13Erlotinib Hydrochloride 10Taxes 8atezolizumab 7Magnetic Resonance Spectroscopy 7Drug Therapy 6Cyclophosphamide 6Bevacizumab 6Platinum 5Gefitinib 5130-nm albumin-bound paclitaxel 5Etoposide 4Biopsy 4Albumin-Bound Paclitaxel 41,2-diaminocyclohexaneplatinum II citrate 4spartalizumab 3sotorasib 3poly ICLC 3capmatinib 3Surveys and Questionnaires 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Non-Small-Cell Lung × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00907699 2014-07-24

Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507

Case Comprehensive Cancer Center

Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡